Berlin Science Week: Tailor-made kids – how biotechnology alters reproduction

Berlin Science Week: Tailor-made kids – how biotechnology alters reproduction

 © KIT, Buedeka

© KIT, Buedeka

Wrap-up event and Paneldiscussion of the project Bürgerdelphi Keimbahntherapie of the Karlsruhe Institute for Technology, supported by BMBF, 6 November 2018, 7 pm

Should we allow the treatment of hereditary diseases by altering the genetic code of human sperm, egg cells or even embryos? With current biotechnologies such as CRISPR, human germline modification becomes an option. The implications of gene editing for the future of human reproduction and our society as a whole are discussed controversially. Some are even concerned that we end up in enhancing humanity beyond what we experience as natural. The BMBF funded project “Bürgerdelphi Keimbahntherapie” (Citizen Delphi Germline Therapy) brought together citizens who participated in discussing the chances and risks of germline modification over the period of several months. The results of the participation programme will be presented this evening for the first time. The event will start with a keynote speech by Sascha Karberg, science editor at the Tagesspiegel and an expert on biotechnology. The subsequent panel discussion will bring together politicians, experts and attendees of the project to discuss the chances and risks of germline modification and possibilities for regulation.

Registration at http://www.buedeka.de/abschlussveranstaltung/